Aurobindo receives FDA approval for rufinamide tablets
EAST WINDSOR, N.J. – Aurobindo Pharma Limited has received final approval from U.S. Food and Drug Administration for its Abbreviated New Drug Application for Aurobindo Receives FDA Approval for rufinamide tablets USP, 200mg and 400mg.